Navigation Links
Techne Corporation Board Member Recognized
Date:6/10/2009

MINNEAPOLIS, June 10 /PRNewswire-FirstCall/ -- Charles A. Dinarello, M.D., a Professor of Medicine at the University of Colorado School of Medicine in Denver and a member of the Techne Corporation Board of Directors, was recently recognized with two distinguished awards.

On April 26, 2009, Dr. Dinarello, Ralph M. Steinman, M.D., of Rockefeller University and Bruce Beutler, M.D., of The Scripps Research Institute, were the 2009 recipients of the Albany Medical Center Prize in Medicine and Biomedical Research for their "groundbreaking discoveries that have transformed the field of immunology." The Prize is the largest award in medicine or science in the United States.

James J. Barba, president and chief executive officer of Albany Medical Center, who served as chairman of the National Selection Committee, in an April press release, said, "Collectively, the work of these scientists has led to a dramatically better understanding of the human immune system, in health and in disease. That knowledge has already directly resulted in new therapies for people with conditions including rheumatoid arthritis, diabetes, Crohn's disease and cancer. And, the discoveries they have made about how the body senses and responds to infection remain the basis of active research that holds the promise of new and improved vaccines and innovative ways to harness the power of the immune system to better fight viruses and bacterial illness. Their achievements are nothing short of astounding."

Dr. Dinarello, along with Professors Tadamitsu Kishimoto, M.D., Ph.D., and Toshio Hirano, M.D., Ph.D., both of Japan, have been named Crafoord Laureates 2009 and were honored by the Royal Swedish Academy of Sciences in ceremonies on May 11, 2009 in Stockholm, Sweden. The laureates received their prize medals from the King of Sweden, Carl Gustav the 16th. The 2009 Crafoord Prize was awarded "for their pioneering work to isolate interleukins, determine their properties and explore their role in the onset of inflammatory diseases." This year´s Crafoord Prize laureates discovered two new key players in the immune system of the human body: the signal substances interleukin-1 (IL-1) and interleukin-6 (IL-6). Child and adult joint-disease sufferers often have high concentrations of these substances in their bodies. Activated by these substances, the immune system then starts to break down cartilage and bone. The Crafoord Prize in astronomy and mathematics, biosciences, geosciences or polyarthritis is awarded by the Royal Swedish Academy of Sciences annually according to a rotating scheme. The Crafoord prize is one of the world´s largest scientific prizes.

Tom Oland, President and Chief Executive Officer of Techne Corporation, stated that "the shareholders and employees of the Company are very fortunate to benefit from Dr. Dinarello's extraordinary experience and commitment to science. Dr. Dinarello has been helpful to the Company and its scientists for many years. On their behalf, we offer sincerest congratulations for these well-deserved recognitions."

Techne Corporation has two operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England. R&D Systems is a specialty manufacturer of biological products. R&D Systems has two subsidiaries, BiosPacific, Inc. (BiosPacific), located in Emeryville, California and R&D Systems China Co. Ltd., (R&D China), located in Shanghai, China. BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits. R&D China and R&D Europe distribute biotechnology products.


'/>"/>
SOURCE Techne Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
2. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
3. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
4. Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program
5. Techne Corporation Declares Dividend
6. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
7. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2008
8. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
9. Techne Corporation Announces Share Repurchase Authorization
10. Mach One Corporation Developing a Nasal, Hand Carried Product as Solution to Swine Flu (H1N1) Virus
11. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit ... 7th and 8th June 2018 in San Francisco, CA. The Summit brings together current ... several distinguished CEOs, board directors and government officials from around the world to address ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
Breaking Biology Technology:
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
Breaking Biology News(10 mins):